ArticleCurrent research in toxicology2021

Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan.

Thu-Lan T Luong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.